Back HIV Treatment Search for a Cure

Search for a Cure

Coverage of the 2013 International AIDS Society Conference

HIVandHepatitis.com coverage of the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), June 30-July 3, in Kuala Lumpur, Malaysia.

Conference highlights include antiretroviral therapy strategies, treatment access, investigational agents for HIV and hepatitis C, management of HIV-related complications, biomedical HIV prevention, and HIV cure research.

Full listing by topic

HIVandHepatitis.com IAS 2013 conference section

7/6/13

alt

 

IAS 2013: Stem Cell Transplant Patients Remain HIV-Free [VIDEO]

Two Boston men with HIV who received bone marrow transplants after a milder conditioning chemotherapy regimen continued to have undetectable virus 7 and 15 weeks after undergoing experimental treatment interruption, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.

alt

Read more:

IAS 2013: German Researchers Report Case of Functional Cure After Very Early HIV Treatment

Another case of prolonged control of HIV replication after stopping treatment was reported on this week at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), indicating that cases of post-treatment control of HIV are not confined to the French VISCONTI cohort.

alt

Read more:

IAS 2013: Boston Stem Cell Transplant Recipients Now Controlling HIV Off Treatment

Two people with HIV who received stem cell transplants to treat lymphoma are now controlling HIV replication without antiretroviral medication in the early weeks of treatment interruption, following the discovery that both had experienced loss of detectable HIV DNA, researchers from Boston reported Wednesday at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.alt

Read more:

IAS 2013: Starting Treatment with CD4s Above 500 Reduces HIV Reservoir during Long-term Infection

People with HIV who start treatment with CD4 counts above 500 cells/mm3, after the first phase of primary infection is over, are much more likely to experience substantial reductions in the reservoir of HIV-infected cells in their bodies, making them strong candidates for future studies that seek to control HIV without medication, French researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.

alt

Read more: